These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 25294558)
1. Cytochrome P450 oxidoreductase deficiency: rare congenital disorder leading to skeletal malformations and steroidogenic defects. Fukami M; Ogata T Pediatr Int; 2014 Dec; 56(6):805-808. PubMed ID: 25294558 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic challenges and management advances in cytochrome P450 oxidoreductase deficiency, a rare form of congenital adrenal hyperplasia, with 46, XX karyotype. Wang C; Tian Q Front Endocrinol (Lausanne); 2023; 14():1226387. PubMed ID: 37635957 [TBL] [Abstract][Full Text] [Related]
3. Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. Zhang J; Woo KL; Hai Y; Wang S; Lin Y; Huang Y; Peng X; Wu H; Zhang S; Yan L; Li Y Front Endocrinol (Lausanne); 2022; 13():1020880. PubMed ID: 36518257 [TBL] [Abstract][Full Text] [Related]
5. P450 oxidoreductase deficiency - a new form of congenital adrenal hyperplasia. Flück CE; Pandey AV; Huang N; Agrawal V; Miller WL Endocr Dev; 2008; 13():67-81. PubMed ID: 18493134 [TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review. Bai Y; Li J; Wang X J Ovarian Res; 2017 Mar; 10(1):16. PubMed ID: 28288674 [TBL] [Abstract][Full Text] [Related]
7. A rare cause of congenital adrenal hyperplasia: Antley-Bixler syndrome due to POR deficiency. Herkert JC; Blaauwwiekel EE; Hoek A; Veenstra-Knol HE; Kema IP; Arlt W; Kerstens MN Neth J Med; 2011 Jun; 69(6):281-3. PubMed ID: 21868813 [TBL] [Abstract][Full Text] [Related]
8. Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency: based on the first cohort of Chinese children. Fan L; Ren X; Song Y; Su C; Fu J; Gong C Orphanet J Rare Dis; 2019 Dec; 14(1):299. PubMed ID: 31888681 [TBL] [Abstract][Full Text] [Related]
9. In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase. Nurhafizuddin M; Azizi A; Ming LC; Shafqat N Molecules; 2022 Jul; 27(14):. PubMed ID: 35889519 [TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. Krone N; Reisch N; Idkowiak J; Dhir V; Ivison HE; Hughes BA; Rose IT; O'Neil DM; Vijzelaar R; Smith MJ; MacDonald F; Cole TR; Adolphs N; Barton JS; Blair EM; Braddock SR; Collins F; Cragun DL; Dattani MT; Day R; Dougan S; Feist M; Gottschalk ME; Gregory JW; Haim M; Harrison R; Olney AH; Hauffa BP; Hindmarsh PC; Hopkin RJ; Jira PE; Kempers M; Kerstens MN; Khalifa MM; Köhler B; Maiter D; Nielsen S; O'Riordan SM; Roth CL; Shane KP; Silink M; Stikkelbroeck NM; Sweeney E; Szarras-Czapnik M; Waterson JR; Williamson L; Hartmann MF; Taylor NF; Wudy SA; Malunowicz EM; Shackleton CH; Arlt W J Clin Endocrinol Metab; 2012 Feb; 97(2):E257-67. PubMed ID: 22162478 [TBL] [Abstract][Full Text] [Related]
11. 46,XX DSD and Antley-Bixler syndrome due to novel mutations in the cytochrome P450 oxidoreductase gene. Guaragna-Filho G; Castro CC; Carvalho RR; Coeli FB; Ferraz LF; Petroli RJ; Mello MP; Sewaybricker LE; Lemos-Marini SH; D'Souza-Li LF; Miranda ML; Maciel-Guerra AT; Guerra-Junior G Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):578-85. PubMed ID: 23295302 [TBL] [Abstract][Full Text] [Related]
12. Clinical and biochemical consequences of p450 oxidoreductase deficiency. Flück CE; Pandey AV Endocr Dev; 2011; 20():63-79. PubMed ID: 21164260 [TBL] [Abstract][Full Text] [Related]
13. P450 Oxidoreductase Deficiency: A Systematic Review and Meta-analysis of Genotypes, Phenotypes, and Their Relationships. Dean B; Chrisp GL; Quartararo M; Maguire AM; Hameed S; King BR; Munns CF; Torpy DJ; Falhammar H; Rushworth RL J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31825489 [TBL] [Abstract][Full Text] [Related]
15. Non-classic cytochrome P450 oxidoreductase deficiency strongly linked with menstrual cycle disorders and female infertility as primary manifestations. Papadakis GE; Dumont A; Bouligand J; Chasseloup F; Raggi A; Catteau-Jonard S; Boute-Benejean O; Pitteloud N; Young J; Dewailly D Hum Reprod; 2020 Apr; 35(4):939-949. PubMed ID: 32242900 [TBL] [Abstract][Full Text] [Related]
16. Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. Tomalik-Scharte D; Maiter D; Kirchheiner J; Ivison HE; Fuhr U; Arlt W Eur J Endocrinol; 2010 Dec; 163(6):919-24. PubMed ID: 20844025 [TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. Fukami M; Horikawa R; Nagai T; Tanaka T; Naiki Y; Sato N; Okuyama T; Nakai H; Soneda S; Tachibana K; Matsuo N; Sato S; Homma K; Nishimura G; Hasegawa T; Ogata T J Clin Endocrinol Metab; 2005 Jan; 90(1):414-26. PubMed ID: 15483095 [TBL] [Abstract][Full Text] [Related]
18. Ambiguous genitalia, impaired steroidogenesis, and Antley-Bixler syndrome in a patient with P450 oxidoreductase deficiency. But WM; Lo IF; Shek CC; Tse WY; Lam ST Hong Kong Med J; 2010 Feb; 16(1):59-62. PubMed ID: 20124576 [TBL] [Abstract][Full Text] [Related]
19. Molecular Basis of CYP19A1 Deficiency in a 46,XX Patient With R550W Mutation in POR: Expanding the PORD Phenotype. Parween S; Fernández-Cancio M; Benito-Sanz S; Camats N; Rojas Velazquez MN; López-Siguero JP; Udhane SS; Kagawa N; Flück CE; Audí L; Pandey AV J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32060549 [TBL] [Abstract][Full Text] [Related]